PEDIATRICS Vol. 38 No. 3 September 1966, pp. 465-472
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutow, W. W.
Right arrow Articles by Windmiller, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutow, W. W.
Right arrow Articles by Windmiller, J.

VINCRISTINE SULFATE THERAPY IN CHILDREN WITH METASTATIC SOFT TISSUE SARCOMA

W. W. Sutow M.D., D. H. Berry M.D., T. B. Haddy M.D., M. P. Sullivan M.D., W. L. Watkins M.D., and Joan Windmiller M.D.

Sixteen children with metastatic or recurrent lesions from soft tissue sarcoma, mostly rhabdomyosarcoma, were treated with vincristine sulfate in a protocol-controlled cooperative study. Complete, though not permanent, regression of tumor occurred in two patients. Significant partial control of disease was achieved in three other children. Gastrointestinal or neurologic side-effects resulted in alteration of drug dosage schedule in 4 of 15 patients. The degree of antitumor activity in several of these cases was such that the further study of the effectiveness of the drug, particularly in combination with surgical and radiation therapy, in children with soft tissue sarcoma seems indicated.

Generic and trade names of drugs: vincristine sulfate—Oncovin; cyclophosphamide—Cytoxan; chlorambucil—Leukeran; dactinomycin—Actinomycin-D.

Submitted on January 19, 1966
Accepted on March 2, 1966




This article has been cited by other articles:


Home page
 JCOHome page
A. S. Pappo, E. Lyden, J. Breneman, E. Wiener, L. Teot, J. Meza, W. Crist, and T. Vietti
Up-Front Window Trial of Topotecan in Previously Untreated Children and Adolescents With Metastatic Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study
J. Clin. Oncol., January 1, 2001; 19(1): 213 - 219.
[Abstract] [Full Text] [PDF]